Conclusion The lipid-lowering therapy with SXBXP and simvastatin could inhibit angiogenesis and degradation of extracellular matrix in the atherosclerotic plaque in the rabbit model.
结论麝香保心丸与辛伐他汀的治疗,可以抑制斑块内新生血管生长,减少斑块内胞外基质的降解,因此可能具有稳定粥样硬化斑块作用。
OBJECTIVE: To evaluate the aspect of clinical usage and progress on different lipid-lowering drugs in therapy of coronary heart disease (CHD).
目的:评价各类降脂药物在冠心病治疗中的研究进展及临床应用情况。
Lipid-lowering plays an important role in therapy of CHD. Early and rational use lipid-lowering drugs would be beneficial for patients with CHD in a long term.
降脂治疗在冠心病的治疗中占有重要地位,及早合理地应用降脂药物,可以使冠心病患者获得长期的受益。
Lipid-lowering plays an important role in therapy of CHD. Early and rational use lipid-lowering drugs would be beneficial for patients with CHD in a long term.
降脂治疗在冠心病的治疗中占有重要地位,及早合理地应用降脂药物,可以使冠心病患者获得长期的受益。
应用推荐